Latest Safety News

EMVision Medical Devices has activated five of six pivotal trial sites for its emu™ bedside brain scanner, advancing towards FDA clearance while launching a parallel innovation study in Australia.

Echo IQ has initiated a pivotal clinical validation study with the Mayo Clinic Platform to test its EchoSolv HF software, marking the final step before its planned FDA submission in late 2025.

Prescient Therapeutics has launched a $7 million Share Purchase Plan at a notable discount to fund the next phase of clinical trials for its promising PTX-100 cancer therapy. The capital raise aims to accelerate progress toward regulatory approval and patient access.

HMC Capital has delayed the Neoen VIC Portfolio acquisition settlement by one month, secured a $200 million mezzanine financing facility, and announced a strategic merger of its renewable energy platforms under new leadership.

SenSen Networks has successfully completed a key contract with Montréal’s Agence de mobilité durable, driving record full-year revenue growth exceeding 20%. The company anticipates strong cash collections into FY26, underscoring its expanding global footprint in AI-driven urban management.

Gibb River Diamonds advances key permits for its Edjudina Gold Project, aiming to begin mining at the Neta Prospect by August 2025 with minimal financial risk.

Actinogen Medical has enrolled its 100th participant in the XanaMIA phase 2b/3 Alzheimer’s trial, setting the stage for a critical interim analysis in January 2026 and final results by year-end.

Dimerix Limited has received a significant milestone payment from its Japanese partner FUSO Pharmaceutical, marking progress in the Phase 3 clinical trial of DMX-200 for kidney disease. This payment underscores the growing momentum behind Dimerix’s global licensing strategy.

LTR Pharma has successfully completed the extractables study for its intranasal erectile dysfunction spray SPONTAN, confirming safety compliance and initiating the next phase of leachables testing to support FDA approval.

Brightstar Resources has completed a Definitive Feasibility Study for its Menzies and Laverton Gold Projects, outlining a robust staged development plan with strong financial returns and a targeted final investment decision in 2025.

WA1 Resources has announced a substantial upgrade to its Luni niobium deposit with a significant Indicated Mineral Resource Estimate and successful ferroniobium production testwork, positioning the West Arunta Project as a key player in the critical minerals sector.

Aquirian Limited has secured $5 million in fresh capital to upgrade its Wubin emulsion facility and accelerate commercialization of its innovative Collar Keeper® technology, alongside a new $1.5 million tolling contract.